IXJ Holdings
124 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | ELI LILLY | 10.70% | 389,734 | $463.3M |
| 2 | JOHNSON & JOHNSON | 7.01% | 1,174,109 | $303.4M |
| 3 | ABBVIE | 5.40% | 860,956 | $233.6M |
| 4 | MERCK & CO INC | 4.35% | 1,319,431 | $188.4M |
| 5 | UNITEDHEALTH GROUP | 4.17% | 480,057 | $180.5M |
| 6 | ROCHE PS PAR AG (ROP.SW) | 3.76% | 376,247 | $162.7M |
| 7 | NOVARTIS AG (NOVN.SW) | 3.27% | 980,621 | $141.4M |
| 8 | ASTRAZENECA PLC (AZN.L) | 3.09% | 830,524 | $133.7M |
| 9 | THERMO FISHER SCIENTIFIC INC | 3.03% | 197,976 | $131.1M |
| 10 | AMGEN INC | 2.76% | 289,435 | $119.6M |
| 11 | GILEAD SCIENCES | 2.26% | 664,723 | $97.6M |
| 12 | ABBOTT LABORATORIES | 2.11% | 926,262 | $91.4M |
| 13 | PFIZER | 1.97% | 3,051,824 | $85.5M |
| 14 | INTUITIVE SURGICAL | 1.81% | 189,383 | $78.5M |
| 15 | DANAHER | 1.69% | 334,786 | $73.1M |
| 16 | VERTEX PHARMACEUTICALS | 1.59% | 135,869 | $68.7M |
| 17 | BRISTOL MYERS SQUIBB | 1.51% | 1,093,037 | $65.3M |
| 18 | NOVO NORDISK CLASS B (NOVO-B.CO) | 1.50% | 1,708,304 | $65.0M |
| 19 | CVS HEALTH | 1.39% | 685,555 | $60.3M |
| 20 | MEDTRONIC PLC | 1.35% | 684,856 | $58.6M |
| 21 | MCKESSON CORP | 1.32% | 62,531 | $56.9M |
| 22 | GLAXOSMITHKLINE (GSK.L) | 1.19% | 2,168,724 | $51.3M |
| 23 | STRYKER | 1.19% | 186,378 | $51.3M |
| 24 | ELEVANCE HEALTH INC | 1.09% | 116,242 | $47.0M |
| 25 | SANOFI SA (SAN.PA) | 1.07% | 576,610 | $46.4M |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 72.29%
- Switzerland: 9.83%
- United Kingdom: 4.95%
- Denmark: 1.92%
- Ireland: 1.35%
- France: 1.75%
- Australia: 1.05%
- Netherlands: 1.08%
- Japan: 3.65%
- Germany: 1.48%
- Belgium: 0.34%
- Luxembourg: 0.12%
- Brazil: 0.12%
- Sweden: 0.07%
- Other: 0.01%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.